BriaCell Therapeutics Corp. Quarterly Stockholders' Equity Attributable to Parent in USD from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
BriaCell Therapeutics Corp. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q2 2020 to Q2 2023.
  • BriaCell Therapeutics Corp. Stockholders' Equity Attributable to Parent for the quarter ending July 31, 2023 was -$3.78M, a 137% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 -$3.78M -$14.1M -137% Jul 31, 2023 10-K 2023-10-25
Q1 2023 -$5.89M -$15.9M -159% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 -$1.28M -$17.7M -108% Jan 31, 2023 10-Q 2023-06-14
Q3 2022 $10.3M +$8.75M +553% Oct 31, 2022 10-Q 2023-03-16
Q2 2022 $10.3M -$17.3M -62.7% Jul 31, 2022 10-K 2023-10-25
Q1 2022 $9.96M Apr 30, 2022 10-Q 2023-06-14
Q4 2021 $16.4M Jan 31, 2022 10-Q 2023-06-14
Q3 2021 $1.58M Oct 31, 2021 10-Q 2023-03-16
Q2 2021 $27.7M +$30.4M Jul 31, 2021 10-K 2023-10-25
Q2 2020 -$2.74M Jul 31, 2020 10-K 2022-10-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.